Results 11 to 20 of about 156,135 (285)

Venom Toxins as Potential Targeted Therapies [PDF]

open access: yesToxins, 2019
Targeted therapy has been a very hot research topic in the last decade [...]
Hang Fai Kwok
doaj   +3 more sources

Targeting Toxins toward Tumors [PDF]

open access: yesMolecules, 2021
Many cancer diseases, e.g., prostate cancer and lung cancer, develop very slowly. Common chemotherapeutics like vincristine, vinblastine and taxol target cancer cells in their proliferating states.
Henrik Franzyk   +1 more
doaj   +4 more sources

Current status and future directions of botulinum neurotoxins for targeting pain processing. [PDF]

open access: yes, 2015
Current evidence suggests that botulinum neurotoxins (BoNTs) A1 and B1, given locally into peripheral tissues such as skin, muscles, and joints, alter nociceptive processing otherwise initiated by inflammation or nerve injury in animal models and humans.
Pellett, Sabine   +2 more
core   +15 more sources

Gene therapy and targeted toxins for glioma. [PDF]

open access: yesCurr Gene Ther, 2011
The most common primary brain tumor in adults is glioblastoma. These tumors are highly invasive and aggressive with a mean survival time of 15-18 months from diagnosis to death. Current treatment modalities are unable to significantly prolong survival in patients diagnosed with glioblastoma.
Castro MG   +12 more
europepmc   +4 more sources

Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861

open access: yesToxins, 2022
Immunotoxins do not only bind to cancer-specific receptors to mediate the elimination of tumor cells through the innate immune system, but also increase target cytotoxicity by the intrinsic toxin activity.
Hossein Panjideh   +3 more
doaj   +1 more source

Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes

open access: yesToxins, 2023
The production of therapeutic recombinant toxins requires careful host cell selection. Bacteria, yeast, and mammalian cells are common choices, but no universal solution exists.
Luana di Leandro   +3 more
doaj   +1 more source

The impact of environmental toxins on the animal gut microbiome and their potential to contribute to disease

open access: yesFood Chemistry Advances, 2023
Environmental toxins have the potential to disrupt the animal gut microbiome (AGM), which can lead to various gut-associated diseases such as inflammatory bowel disease (IBD) and colorectal cancer.
Dinesh Nalage   +7 more
doaj   +1 more source

Aedes cadherin receptor that mediates Bacillus thuringiensis Cry11A toxicity is essential for mosquito development. [PDF]

open access: yes, 2020
Aedes cadherin (AaeCad, AAEL024535) has been characterized as a receptor for Bacillus thuringiensis subsp. israelensis (Bti) Cry11A toxins. However, its role in development is still unknown.
Aimanova, Karly G   +2 more
core   +2 more sources

Toxins, Targets, and Triggers: An Overview of Toxin-Antitoxin Biology [PDF]

open access: yesMolecular Cell, 2018
Bacterial toxin-antitoxin (TA) modules are abundant genetic elements that encode a toxin protein capable of inhibiting cell growth and an antitoxin that counteracts the toxin. The majority of toxins are enzymes that interfere with translation or DNA replication, but a wide variety of molecular activities and cellular targets have been described ...
Harms, Alexander   +3 more
openaire   +5 more sources

"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? [PDF]

open access: yes, 2007
Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway.
Medina-Kauwe, LK
core   +1 more source

Home - About - Disclaimer - Privacy